CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-08 | Wang Xiaodong Director | Sale | −677 | $354.18 | $240K | 608 |
| 2021-11-08 | Wang Xiaodong Director | Sale | −308 | $355.15 | $109K | 300 |
| 2021-11-08 | Wang Xiaodong Director | Sale | −100 | $357.25 | $36K | 200 |
| 2021-11-08 | Wang Xiaodong Director | Sale | −200 | $359.97 | $72K | 0 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −300 | $343.12 | $103K | 7,366 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −300 | $345.06 | $104K | 7,066 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −300 | $346.43 | $104K | 6,766 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −420 | $347.20 | $146K | 6,346 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −449 | $348.70 | $157K | 5,897 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −164 | $349.66 | $57K | 5,733 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −300 | $351.28 | $105K | 5,433 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −100 | $352.76 | $35K | 5,333 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −300 | $354.03 | $106K | 5,033 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −300 | $355.32 | $107K | 4,733 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −200 | $358.59 | $72K | 4,533 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −4,433 | $360.08 | $1.6M | 100 |
| 2021-11-08 | Wu Xiaobin President, COO & GM China | Sale | −100 | $361.03 | $36K | 0 |
| 2021-10-31 | Wang Lai Global Head of R&D | Gift | −58,188 | 0 | ||
| 2021-10-31 | Wang Lai Global Head of R&D | Gift | +58,188 | 58,188 | ||
| 2021-10-19 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $119.96 | $180K | 1,500 |
Page 56 of 71 · 1,406 trades